Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Renew Dental Diminishes Fear by Protecting Patients and Staff From COVID-19 Using Surfacide’s Proven UV Technology

FOR IMMEDIATE RELEASE Renew Dental is the first dental practice in the United States to adopt Surfacide–a powerful and innovative technology to combat COVID-19 head on and provide a safer environment for patients and staff. The leading Phoenix dental facility is using Surfacide’s proven UV-C system to decontaminate surfaces to address the concerns of SARS-CoV-2…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Renew Dental Diminishes Fear by Protecting Patients and Staff From COVID-19 Using Surfacide’s Proven UV Technology

FOR IMMEDIATE RELEASE

Renew Dental is the first dental practice in the United States to adopt Surfacide–a powerful and innovative technology to combat COVID-19 head on and provide a safer environment for patients and staff. The leading Phoenix dental facility is using Surfacide’s proven UV-C system to decontaminate surfaces to address the concerns of SARS-CoV-2 and COVID-19.

Staff at Renew Dental were pleasantly surprised to see the technology at work, decontaminating patient rooms in as little as five minutes. Dr. Gwen Multine, DMD, discovered the Surfacide system when researching UV technology and knew her patients and workers would be appreciative in the dental practices’ investment in their safety.

“Our office is perfect for the Surfacide system. When the pandemic began, we were looking for something that would not just give the illusion of safety or spray chemicals into the air,” says Dr. Gwen Multine. “Surfacide accomplishes that while making our patients and technicians feel safer.”

Surfacide is being used to decontaminate rooms daily and Renew Dental has not reported any positive COVID-19 cases since its implementation. Each day, Renew Dental’s EVS team runs Surfacide in the exam rooms, cleans the space by hand and runs the Surfacide system once more for an additional layer of protection. The Surfacide system is the first of its kind to use a triple emitter UV-C technology to laser map the room and significantly reduce the presence of viruses and bacteria in a single, rapid cycle.

“Renew Dental is a unique partner of ours as they are the first dental office in the U.S. to implement Surfacide’s technology, and we are very impressed with their proactive infection prevention initiatives to address COVID-19,” says Gunner Lyslo, Founder and CEO of Surfacide. “COVID-19 has made critical healthcare tasks like visiting the dentist something that many may delay doing for fear of the current pandemic. Surfacide and clinics like Renew dental are here to reduce that fear and provide a sense of normalcy back to everyday life.”

About Surfacide LLC

Surfacide LLC and Surfacide Manufacturing Inc., are located in Waukesha, WI and produce multiple emitter UV-C systems.

Surfacide is the only triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and other hospital-acquired infections. Over 400 hospitals nationally and internationally are using Surfacide technology to provide an extra layer of protection for patients

and healthcare workers. Surfacide’s evidence-based UV-C solution addresses shadows and provides greater coverage for quicker turnaround time and better care. Patients and healthcare workers around the world choose Surfacide as a trusted partner in infection prevention.

Our mission is to provide patients and healthcare workers with a safe environment and continuous support in infection prevention. We respect and admire the dedication from healthcare professionals and in turn, deliver advanced technology that your team needs to provide the best care possible. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.

For More Information Contact

Sarah Kotlan | Marketing Coordinator Surfacide, LLC (262) 501-4900 | sarah.kotlan@surfacide.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512